Post-LTPL Organ Dysfunction - Non-invasive diagnostic with aid of plasmatic apoptosis markers

Post-LTPL Organ Dysfunction - Non-invasive diagnostic with aid of plasmatic apoptosis markers - CaspAct-LTPL (=Caspase Activation in Liver Transplantation)-Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003434

Enrollment

150

Registered

2012-01-11

Start date

2009-05-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing orthotopic liver transplantation from deceased donors C22.0 K74.6

Interventions

Group 1: Control group: No complication within the 10-day observation period Group 2: Vascular complication within the 10-day observation period Group 3: Biliary complication within the 10-day observa

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Liver transplantation from deceased donors

Exclusion criteria

Exclusion criteria: Not meeting the inclusion criteria, refusing study participation

Design outcomes

Secondary

Measure	Time frame
Development of a complication (vascular complication, biliary complication, rejection, infection) within 180 days after transplantation	—

Primary

Measure	Time frame
Development of a complication (vascular complication, biliary complication, rejection, infection) within 10 days after transplantation	—

Countries

Germany

Contacts

Public ContactStefan Hofer

Klinik für Anaesthesiologie Uniklinkum Heidelberg

stefan.hofer@med.uni-heidelberg.de06221 5637787

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026